Avery Dennison, in collaboration with Becton, Dickinson and Company (BD), has introduced an RFID-enabled solution for the traceability of pre-filled syringes (PFS). The innovation, called BD iDFill™ Individual Prefillable Syringe Identification, integrates RFID tags into the syringe’s rigid needle shield, which allows the product to maintain its original design while gaining a digital identity. This embedded RFID carries a unique identifier, enabling unit-level traceability throughout the PFS’s lifecycle. It also facilitates PFS authentication at the point of care.
Heikki Haavisto, managing director of Turck Vilant Systems, commented, “The transformative power of RFID lies in its ability to uniquely identify individual items, moving beyond traditional batch monitoring. Our industrial customers already save time and reduce costs with RFID adoption, and we foresee a similar trajectory benefiting pharmaceutical companies.” Turck Vilant’s software applications will support the reliable identification of syringes, with demonstrations available during Pharmapack 2025.
Barbara Van Rymenam, senior director of healthcare at Avery Dennison Smartrac, added, “By tracing individual units, manufacturers can mitigate risk related to mix-ups, and use advanced analytics to optimize the manufacturing process. The solution is designed to meet stringent industry requirements, while enhancing operational efficiency.”
This RFID solution aims to meet the pharmaceutical industry’s growing demand for traceability, providing a more efficient and secure method for managing pre-filled syringe distribution. The partners will demonstrate this innovation at Pharmapack 2025, where they will also showcase a range of pharmaceutical labeling materials, including RFID-enabled solutions and cold chain labels.